Skip to main content

The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30

The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, October 30, 2019 at 8:30 a.m. EDT to discuss its third quarter 2019 financial results and operational developments.

The conference call may be accessed by telephone as follows:

U.S./Canada:

(877) 407-0312

International:

(201) 389-0899

Conference ID:

13696004

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website.

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

U.S./Canada:

(877) 660-6853

International:

(201) 612-7415

Conference ID:

13696004

An archived webcast will be also be available after the call concludes.

About The Medicines Company

The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today – cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL cholesterol. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

Contacts:

Investor Relations
Krishna Gorti, M.D.
Vice President, Investor Relations
973 290 6122
krishna.gorti@themedco.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.